Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dodson, W. E.
Right arrow Articles by Siegel, B. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dodson, W. E.
Right arrow Articles by Siegel, B. A.
NEUROLOGY 1979;29:749
© 1979 American Academy of Neurology

Radionuclide imaging in subacute sclerosing panencephalitis

W. Edwin Dodson, Arthur L. Prensky and Barry A. Siegel

Edward Mallinckrodt Department of Pediatrics, the Departments of Neurology and Neurological Surgery (Neurology), and the Edward Mallinckrodt Institute of Radiology, Washington University School of Medicine, and the Division of Pediatric Neurology of St. Louis Children's Hospital, St. Louis, Missouri.

Three patients with subacute sclerosing panencephalitis (SSPE)—two with acute disease and one with an exacerbation—had abnormal radionuclide brain scans during periods of rapid neurologic deterioration. In two of the three patients radionuclide brain scan showed lesions of both cortex and deeper structures, indicating the panencephalic nature of the disease. There was no contrast enhancement on computerized tomography (CT) in the areas of radiopharmaceutical accumulation in the two patients studied. We feel that delayed radionuclide scanning is more sensitive in detecting acute SSPE than routine contrast-enhanced CT, because more time is allowed for tracer accumulation in lesions and for background activity to decrease.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1979 by AAN Enterprises, Inc.